MedTrace Logo

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea

NCT00212342 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2010-09-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether combination oral contraceptive pill of Norethindrone \& Ethinyl estradiol is effective in the treatment of dysmenorrhea associated with endometriosis.

Conditions

  • Dysmenorrhea

Interventions

DRUG

Norethisterone,Ethinylestradiol

DRUG

Sugar pill

Sponsors & Collaborators

  • Nobelpharma

    lead INDUSTRY

Principal Investigators

  • Naoki Terakawa, M.D.,Ph.D. · Tottori University,Tottori,Japan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2006-01-31
Completion
2006-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00212342 on ClinicalTrials.gov